Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Small Molecule May Disrupt Biofilm Formation on Implantable Medical Devices


Medical Device

These medical devices are vulnerable to colonization by pathogenic bacteria, including the dangerous methicillin-resistant Staphylococcus aureus (MRSA).

Share this!

March 28, 2017 | by Sarah Hand, M.Sc.

Researchers at Trinity College Dublin in Ireland have identified a small molecule capable of preventing bacterial biofilms from growing on medical implants. These medical devices are vulnerable to colonization by pathogenic bacteria, including the dangerous methicillin-resistant Staphylococcus aureus (MRSA).

While bacterial cells on their own can cause infections in individuals, these pathogens are even stronger when they colonize a surface in large numbers. Bacterial species can excrete a sticky extracellular matrix which allows them to adhere to a surface and be protected from external factors.

Bacterial biofilms can form in wounds, on the surface of the skin and even within plaques in the teeth. However, when these biofilms form on implantable medical devices – such as pacemakers, catheters and artificial hips – they can lead to dangerous internal infections which require additional surgery and aggressive treatment.

In the current study, the researchers focused on identifying ways to disrupt the bonds that form between proteins that make up the biofilm. Specifically, they identified a protein known as SdrC, which is found on the surface on certain bacterial cells.

SdrC has been found to fulfill two roles: the protein helps bacterial cells adhere to surfaces, as well as adhere to surrounding bacterial cells. When the researchers introduced a small molecule derived from the presynaptic protein, β-neurexin, into cell culture, they found that the compound could block the act of the SdrC protein.

The small molecule was able to both block the protein’s interaction with other cells, as well as with surfaces. This mode of action effectively prevented the bacteria from forming a biofilm.

“This exciting breakthrough will inform the design of new, targeted approaches to prevent biofilm formation by staphylococci and reduce the incidence of medical device-related infection,” said Dr. Joan A. Geoghegan of Trinity College Dublin. According to the researchers, this compound could be applied to implantable medical devices in the future to prevent biofilm formation before it starts.

Keywords: Biofilm, Medical Device, MRSA


Share this with your colleagues!

Canadian Regulator Recalls Pie Shells Over E. Coli Contaminated Flour

April 28, 2017 - Multiple brands of pie and tart shells are being recalled in Canada after the flour used to manufacture them was linked to 28 cases of illness due to infection with E. coli O121.

Featured In: Food News

FDA Sends Warning Letters to Manufacturers of Fake Cancer Drugs

April 27, 2017 - The FDA is cracking down on the sale of illegal cancer drugs by sending warning letters to 14 US companies selling the unapproved products.

Featured In: Life Science News, Drug Safety News

Womb-Like Device Could Increase Survival of Premature Babies

April 27, 2017 - Researchers at the Children's Hospital of Philadelphia (CHOP) have developed a womb-like device which mimics the environmental conditions found inside the uterus.

Featured In: Life Science News, Medical Device News


What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation


Technology Solutions for Late Phase Research: Optimising Real World Data Assets

Serialization for Late Starters – With Live Industry Research Results

Clinical Not All Antioxidants Are Created Equal: Astaxanthin, The Antioxidant Powerhouse

The New Gold Standards of IRT Delivery for Clinical Trials

Copyright © 2016-2017 Honeycomb Worldwide Inc.